Right now we are on a serious downtrend in this stock. Biotech in general is being looked at carefully. The big questions are being asked. And Progen is coming up short.
We will soon be below $4, and that may trigger a wave of secondary selling. I wouldn't be surprised to see this under $3 by the end of the year. People need to remember that there are many sitting on significant profits, and they will want to lock them in before they erode completely.
This company has many years before it can turn a profit, and that's if everything goes to plan.
We're going further south, of that you can be sure.
2007 australian bio investment forum, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
-0.005(1.12%) |
Mkt cap ! $72.46M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 44.0¢ | $10.48K | 23.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1124106 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 1389 | 1 |
View Market Depth
| Last trade - 10.10am 12/07/2024 (20 minute delay) ? |
| PGL (ASX) Chart |